Tuberculosis diagnostic delay and therapy outcomes of non-national migrants in Tel Aviv, 1998-2008

Eurosurveillance

Volumn 18, Issue 12, 2013, Pages

  Mor, Z ^a   Kolb, H ^b   Lidji, M ^c   Migliori, G B ^d   Leventhal, A ^a,e  

^a MINISTRY OF HEALTH   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c Israeli Medical Association   (Israel)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

^e HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COMORBIDITY; DELAYED DIAGNOSIS; EMPLOYMENT STATUS; FEMALE; HEALTH INSURANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMIGRANT; ISRAEL; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PREVALENCE; RETROSPECTIVE STUDY; SMOKING; THERAPY DELAY; THORAX RADIOGRAPHY; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 84875544432     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. International Organization of Migration (IOM). World migration report 2010. Geneva: IOM; 2011. Available from: http://publications.iom.int/bookstore/free/WMR2010_summary.pdf.
2. Falzon D, van Cauteren D. Demographic features and trends in tuberculosis cases in the European Region, 1995-2005. Euro Surveill. 2008;13(12): pii=8075. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=8075
3. Horsburgh CR Jr. Priorities for the treatment of latent tuberculosis infection in the United States. N Eng J Med. 2004;350(20):2060-7. http://dx.doi.org/10.1056/NEJMsa031667. PMid:15141044
4. Centres for Disease Control and Prevention (CDC). Trends in tuberculosisUnited States, 2007. MMWR Morb Mortal Wkly Rep. 2008;57(11):281-5.
5. Dara M, de Colombani P, Petrova-Benedict R, Centis R, Zellweger JP, Sandgren A, et al. The minimum package from cross-border control and care in the WHO European region: a Wolfheze consensus statement. Eur Respir J 2012;40(5):1081-90. http://dx.doi.org/10.1183/09031936.00053012 PMid:22653772 PMCid:3485571
6. Heldal E, Kuyvenhoven JV, Wares F, Migliori GB, Ditiu L, Fernandez de la Hoz K, et al. Diagnosis and treatment of tuberculosis in undocumented migrants in lowor intermediate-incidence countries. Int J Tuberc Lung Dis. 2008;12(8):878-88. PMid:18647446
7. Population, immigration and Border Authority. Data on foreigners in Israel. Jul 2011. Hebrew. Available from: http://www.piba.gov.il/PublicationAndTender/ForeignWorkersStat/Documents/july2011.pdf.
8. Mor Z, Lerman Y, Leventhal A. Pre-immigration screening process and pulmonary tuberculosis among Ethiopian migrants in Israel. Eur Respir J. 2008;32(2):413-8. http://dx.doi.org/10.1183/09031936.00145907 PMid:18385171
9. Diez MJ, Bleda MJ, Alcaide J, Caloto T, Castells C, Cardenal JI, et al. Determinants of patient delay among tuberculosis case in Spain. Eur J Pub Health. 2005; 343-9. PMid:16014664
10. Strola DG, Yimer S, Bjune GA. A systematic review of delay and treatment of tuberculosis. BMC Public Health. 2008; 8:15. http://dx.doi.org/10.1186/1471-2458-8-15 PMid:18194573 PMCid:2265684
11. Veen J, Raviglione M, Rieder HL, Migliori GB, Graf P, Grzemska M, et al. Standardized tuberculosis treatment outcome monitoring in Europe. Recommendations of a Working Group of the World Health organization (WHO) and the European Region of the International Union against Tuberculosis and Lung Disease (IUATLD) for uniform reporting by cohort analysis of treatment outcome in tuberculosis patients. Eur Respir J. 1998;12(2):505-10. http://dx.doi.org/10.1183/09031936.98.12020505 PMid:9727811
12. Ali JS, McDermott S, Gravel RG. Recent research on immigrants health from statistics Canada's population surveys. Can J Public Health. 2004;95(3):I9-13. PMid:15191126
13. Achkar JM, Sherpa T, Cohen HW, Holzman RS. Differences in clinical presentation among persons with pulmonary tuberculosis: A comparison of documented and undocumented foreign born versus US-born persons. Clin Infect Dis. 2008;47(10):1277-83. http://dx.doi.org/10.1086/592572PMid:18834320 PMCid:2746906
14. Gagliotti C, Resi D, Moro ML. Delay in the treatment of pulmonary TB in a changing demographic scenario. Int J Tuberc Lung Dis. 2006;10(3):305-9. PMid:16562711
15. Sanz B, Blasco T; ATBIM Project. Variables associated with diagnostic delay in immigrant groups with tuberculosis in Madrid. Int J Tuberc Lung Dis. 2007;11(6): 639-46. PMid:17519095
16. Lin HP, Deng CY, Chou P. Diagnosis and treatment delay among pulmonary tuberculosis patients identified using the Taiwan reporting enquiry system, 2002-2006. BMC Public Health. 2009; 9:55. http://dx.doi.org/10.1186/1471-2458-9-55 PMid:19216733 PMCid:2654887
17. Machado AC, Steffen RE, Oxlade O, Menzies D, Kritski A, Trajman A. Factors associated with delayed diagnosis of pulmonary tuberculosis in the state of Rio de Janeiro, Brazil. J Bras Pneumol. 2011;37(4):512-20. http://dx.doi.org/10.1590/S1806-37132011000400014 PMid:21881742
18. Tala E. Tuberculosis care in foreigners: ethical considerations. Eur Respir J. 1994:7(8):1395-6. http://dx.doi.org/10.1183/09031936.94.07081395 PMid:7957824
19. Sagbakken M, Bjune GA, Frich JC. Experience of being diagnosed with tuberculosis among immigrants in Norway-Factors associated with diagnostic delay: A qualitative study. Scand J Public Health. 2010;38(3):283-90. http://dx.doi.org/10.1177/1403494809357101 PMid:20056784
20. World Health Organization (WHO); International Union Against Tuberculosis and Lung Disease (IUATLD); Royal Netherlands Tuberculosis Association (KNCV). Revised international definition in tuberculosis control. Int J Tuberc Lung Dis. 2001;5(3):213-5. PMid:11326818